[1]赵辨.临床皮肤病学.3版.南京:江苏科技出版社,2001: 123.] [2] Shim JH, Kim YS, Bahk YY. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells .Proteomics,2006,6(1):81-93. [3]N. R. Gough. PI3K-Independent Function of PTEN. Sci.Signal.2009, 2(94): 346. [4]Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275(5308): 1943-1947. [5]Waite KA , Eng C. Protein PTEN: form and function . Am J Hum Genet , 2002,70 (4):829-844. [6]Kuhajda FR. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res, 2006, 66(12):5977-5980. [7]Hagenbeek TJ, Naspetti M, Malergue F, et al. The loss of PTEN allows TCR lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med, 2004, 200(7):883- 894. [8]Li X, Lin G, Wu B, et al. Overexpression of PTEN induces cell growth arrest and apop tosis in human breast cancer ZR-75-1cells. Acta Biochim Biophys Sin ( Shanghai) , 2007, 39(10) : 745. [9]Patrawala L, Calhoun T, Schneider - Broussard R, et al. Side population is enriched in tumorigenic, stem- like cancer cells, whereas ABCG2 + and ABCG2 - cancer cells are similarly tumorigenic. Cancer Res, 2005, 65(14): 6207-6219. [10]Reifenberger J. Basal cell carcinoma. Molecular genetics and unusual clinical features. Hautarzt, . 2007,58(5):406–411. [11]Hill R,Wu H.PTEN, stem cells, and cancer stem cells. J Biol Chem,2009,284(18): 11755- 11759. [12]He YY, Pi J, Huang JL, et al. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene, 2006,25(26): 3680–3688. [13]Backman SA, Ghazarian D, So K, et al. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA, 2004, 101(6): 1725–1730. [14]He XC, Yin T, Grindley JC, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet,2007,39(2):189–198. [15] Shen WH, Balajee AS, Wang J, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 2007,128(1):157–170. [16]Alireza Mirmohammadsadegh, Alessandra Marini, Sandeep Nambiar, et al. Epigenetic Silencing of the PTEN Gene in Melanoma. Cancer Res,2006,66(13):6546-6552. [17]Russo AE, Torrisi E, Bevelacqua Y, et al. Melanoma: molecular pathogenesis and emerging target therapies. Int J Oncol,2009,34(6):1481-1489. [18]Waldmann V ,Wacker J ,Deichmann M. Absence of mutations in the pleckstrin homology (PH) domain of protein kinase B (PKB/ Akt) in malignant melanoma. Melanoma Res ,2002,12(1): 45. [19]Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat,2007,28(6):578–588. [20]He YY, Pi J, Huang JL, et al. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene, 2006,25(26): 3680–3688. [21]Oh JH, Kim A, Park JM, et al. Ultraviolet B-induced matrix metalloproteinase-1 and -3 secretions are mediated via PTEN/Akt pathway in human dermal fibroblasts. J Cell Physiol, 2006,209(3):775–785. [22]Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol, 2000, 156(5):1693–1700.